Related Experiment Videos

Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells

X Song1, S Perkins, B S Jortner

  • 1Laboratory for Neurotoxicity Studies, Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg 24061-0442, USA.

Neurotoxicology
|January 1, 1997
PubMed

Insights

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite MPP+ cause neurotoxic effects in human neuroblastoma cells. These toxins alter cell morphology and mitochondrial function at lower concentrations than those affecting cell viability.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin implicated in Parkinson's disease.
  • SH-SY5Y human neuroblastoma cells are a common model for studying neuronal toxicity.

Purpose of the Study:

  • To evaluate the toxic effects of MPTP and its metabolite MPP+ on SH-SY5Y cells.
  • To investigate the morphological and metabolic changes induced by MPTP and MPP+.

Main Methods:

  • Exposure of SH-SY5Y cells to varying concentrations of MPTP and MPP+.
  • Assessment of cell viability, NADH dehydrogenase activity, and cell morphology.
  • Ultrastructural analysis of mitochondria and cytoskeleton.

Main Results:

  • MPP+ decreased cell viability at 10(-4) M, while MPTP required higher concentrations (3 x 10(-3) M).
  • MPTP and MPP+ inhibited NADH dehydrogenase activity at concentrations above 10(-4) M.
  • MPTP altered cell morphology (blebs, attenuated neurites) and induced mitochondrial/cytoskeletal damage at lower concentrations than those affecting viability.

Conclusions:

  • MPTP-induced neurotoxicity in SH-SY5Y cells involves early morphological and mitochondrial alterations.
  • These structural and functional changes precede significant loss of cell viability and may contribute to MPTP's neurotoxic mechanism.

Related Concept Videos